Cite Filings / INDP / 0001493152-25-029594
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13D/A

Beneficial Ownership Report

Indaptus Therapeutics, Inc. · Filed 2025-12-30 · Acc 0001493152-25-029594

Documents 1

  • SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

  • 2026-03-24 SCHEDULE 13D/A Beneficial Ownership Report
  • 2025-12-30 SCHEDULE 13D/A Beneficial Ownership Report
  • 2025-12-30 SCHEDULE 13D/A Beneficial Ownership Report
  • 2025-12-29 4 Chief Financial Officer acquired 26,758 shares (grant or award)
  • 2025-12-29 4 Co-Chief Executive Officer acquired 216,617 shares (grant or award)
  • 2025-12-29 4 CSO and Director acquired 52,204 shares (grant or award)
  • 2025-12-29 4 Chief Operating Officer acquired 54,421 shares (grant or award)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…